{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:48:00Z","timestamp":1781880480988,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["B2017\/BMD3751"],"award-info":[{"award-number":["B2017\/BMD3751"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["CAS19\/00133"],"award-info":[{"award-number":["CAS19\/00133"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1160465"],"award-info":[{"award-number":["1160465"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["EIN2019-1032 94"],"award-info":[{"award-number":["EIN2019-1032 94"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["IJC2018-035187-I"],"award-info":[{"award-number":["IJC2018-035187-I"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.nefroe.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T03:32:31Z","timestamp":1626233551000},"page":"244-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Interleukin-17A: Potential mediator and therapeutic target in hypertension"],"prefix":"10.1016","volume":"41","author":[{"given":"Ra\u00fal R.","family":"Rodrigues-Diez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tejera-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Orejudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marquez-Exposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Santos-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rayego-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cantero-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tejedor-Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mezzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Selgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Valdivielso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lavoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ruiz-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2021.06.003_bib0005","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.2541","article-title":"Under pressure: the search for the essential mechanisms of hypertension","volume":"17","author":"Coffman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/hr.2016.35","article-title":"Hypertension as an autoimmune and inflammatory disease","volume":"39","author":"Solak","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","article-title":"Oxidative stress, inflammation, and vascular aging in hypertension","volume":"70","author":"Guzik","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans","volume":"68","author":"Itani","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-016-0628-7","article-title":"Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence","volume":"18","author":"Caillon","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nefro.2019.04.006","article-title":"La participaci\u00f3n de la inmunidad en la patogenia de la hipertensi\u00f3n arterial","volume":"40","author":"Rodr\u00edguez-Iturbe","year":"2020","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000179322","article-title":"Autoimmune factors associated with infarction of the kidney","volume":"1","author":"White","year":"1964","journal-title":"Nephron"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2010.10.003","article-title":"Interleukin 17 in vascular inflammation","volume":"21","author":"Von Vietinghoff","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in Chronic Inflammation: From Discovery to Targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1681\/ASN.2010050536","article-title":"The emergence of Th17 cells as effectors of renal injury","volume":"22","author":"Kitching","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1681\/ASN.V981526","article-title":"Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection","volume":"9","author":"Van Kooten","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","article-title":"The role of interleukin-17A in the pathogenesis of kidney diseases","volume":"49","author":"Cortvrindt","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cyto.2008.12.024","article-title":"IL-17F: regulation, signaling and function in inflammation","volume":"46","author":"Chang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0090","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0095","article-title":"Crystal structures of interleukin 17A and its complex with IL-17 receptor A","volume":"4","author":"Liu","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications","volume":"10","author":"Monin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0105","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jimmunol\/175.1.5","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986","volume":"175","author":"Mosmann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0120","first-page":"19","article-title":"Basic aspects of T helper cell differentiation","volume":"vol. 1514","author":"Gagliani","year":"2017"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cyto.a.22348","article-title":"T helper cells plasticity in inflammation","volume":"85","author":"Cosmi","year":"2014","journal-title":"Cytom Part A"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cei.13050","article-title":"CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?","volume":"191","author":"Mesquita","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease","volume":"16","author":"Dupage","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01694","article-title":"IL-17 in peritoneal dialysis-associated inflammation and angiogenesis: conclusions and perspectives","volume":"9","author":"Witowski","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF02591635","article-title":"Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease","volume":"21","author":"Romagnani","year":"1992","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0160","article-title":"Th17 response and inflammatory autoimmune diseases","volume":"2012","author":"Waite","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0034-5288(91)90011-C","article-title":"Lack of LH response to oestradiol treatment in cows with cystic ovarian disease and effect of progesterone treatment or manual rupture","volume":"51","author":"Nanda","year":"1991","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-\u03b2, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00348","article-title":"Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases","volume":"11","author":"Capone","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0190","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of Interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0195","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: an in vivo requirement for STAT3 signaling in T H 17 development and T H 17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/eurheartj\/ehs399","article-title":"Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown","volume":"34","author":"Liuzzo","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0205","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0210","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0215","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0225","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2013.67","article-title":"The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response","volume":"93","author":"Rodrigues-D\u00edez","year":"2013","journal-title":"Lab Investig"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0230","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1159\/000343327","article-title":"Angiotensin II induces TSLP via an AT1 receptor\/NF-KappaB pathway, promoting Th17 differentiation","volume":"30","author":"Zhao","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2014.33","article-title":"IL-17A is a novel player in dialysis-induced peritoneal damage","volume":"86","author":"Rodrigues-D\u00edez","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.06.016","article-title":"Interleukin 17A in atherosclerosis \u2013 regulation and pathophysiologic effector function","volume":"122","author":"Nordlohne","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2015.05.007","article-title":"The paradoxical role of IL-17 in atherosclerosis","volume":"297","author":"Gong","year":"2015","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0255","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000317400","article-title":"Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species","volume":"48","author":"Pietrowski","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/sji.12030","article-title":"IL-17 induces expression of vascular cell adhesion molecule through signalling pathway of NF-\u03baB, but not Akt1 and TAK1 in vascular smooth muscle cells","volume":"77","author":"Zhang","year":"2013","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0270","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0275","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1172\/JCI87344","article-title":"Erratum: Motif mimetic of epsin perturbs tumor growth and metastasis (Journal of Clinical Investigation(2015)125: 12(4349-4364)Doi: 10.1172\/JCI80349)","volume":"126","author":"Dong","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0280","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2007.11.013","article-title":"Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy","volume":"41","author":"Shen","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0285","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.2147\/CMAR.S174899","article-title":"IL-17 induces macrophages to M2-like phenotype via NF-\u03baB","volume":"10","author":"Shen","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0290","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5103672","article-title":"IL-17 receptor signaling negatively regulates the development of tubulointerstitial fibrosis in the kidney","volume":"2018","author":"Ramani","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2362.2001.00743.x","article-title":"Pro-inflammatory cytokines in patients with essential hypertension","volume":"31","author":"Peeters","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0300","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.119.12604","article-title":"Markers or makers: inflammatory cytokines in treatment-resistant hypertension","volume":"73","author":"Barbaro","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0305","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3159283","article-title":"Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker?","volume":"2019","author":"Tanase","year":"2019","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0310","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jch.12612","article-title":"Elevated serum level of interleukin 17 in a population with prehypertension","volume":"17","author":"Yao","year":"2015","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1600-6143.2011.03529.x","article-title":"IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection","volume":"11","author":"Loverre","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/jcm6070068","article-title":"Pathogenic role of IL-17-producing immune cells in obesity, and related inflammatory diseases","volume":"6","author":"Chehimi","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0325","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01015","article-title":"Interleukin 17A participates in renal inflammation associated to experimental and human hypertension","volume":"10","author":"Orejudo","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0330","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0335","doi-asserted-by":"crossref","first-page":"L609","DOI":"10.1152\/ajplung.00531.2016","article-title":"Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension","volume":"312","author":"Maston","year":"2017","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0340","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.117.09374","article-title":"Regulatory T-cell augmentation or interleukin-17 inhibition prevents calcineurin inhibitor-induced hypertension in mice","volume":"70","author":"Chiasson","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0345","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jacbts.2016.07.009","article-title":"Inhibition of interleukin-17A, but not interleukin-17F, signaling lowers blood pressure, and reduces end-organ inflammation in angiotensin II\u2013induced hypertension","volume":"1","author":"Saleh","year":"2016","journal-title":"JACC Basic to Transl Sci"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0350","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1182\/blood-2009-01-198028","article-title":"V\u03b41 T lymphocytes producing IFN-\u03b3 and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans","volume":"113","author":"Fenoglio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0355","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0360","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0020-711X(87)90131-5","article-title":"Rapid procedure for preparation of macrophage plasma membrane","volume":"19","author":"Shibata","year":"1987","journal-title":"Int J Biochem"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0365","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-019-0907-1","article-title":"Innate and innate-like immune system in hypertension and vascular injury","volume":"21","author":"Higaki","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2011.04.060","article-title":"Interleukin-17F increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis","volume":"96","author":"Hirata","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/HYPERTENSIONAHA.113.02604","article-title":"\u03b3\u03b4T cell-derived interleukin-17A via an interleukin-1\u03b2-dependent mechanism mediates cardiac Injury and Fibrosis in hypertension","volume":"64","author":"Li","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0380","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0385","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/HYPERTENSIONAHA.113.02620","article-title":"Deficiency of the interleukin 17\/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin II-induced hypertension","volume":"63","author":"Krebs","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0390","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0395","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20190682","article-title":"Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation","volume":"134","author":"Orejudo","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0400","doi-asserted-by":"crossref","first-page":"579.e1","DOI":"10.1016\/j.jash.2018.06.010","volume":"12","author":"Whelton","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0405","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/hy09t1.096249","article-title":"Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis","volume":"38","author":"Intengan","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0410","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0415","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/eurheartj\/ehp477","article-title":"Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies","volume":"30","author":"Klingenberg","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/iub.1344","article-title":"Inflammation in arterial diseases","volume":"67","author":"Carbone","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0425","doi-asserted-by":"crossref","first-page":"319","DOI":"10.17219\/acem\/37123","article-title":"The role of chemokines in hypertension","volume":"23","author":"Martynowicz","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0430","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cvr\/cvs298","article-title":"Importance of endothelial NF-\u03baB signalling in vascular remodelling and aortic aneurysm formation","volume":"97","author":"Saito","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0445","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/CS20090557","article-title":"Role of nuclear factor \u03baB in cardiovascular health and disease","volume":"118","author":"Van Der Heiden","year":"2010","journal-title":"Clin Sci"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0450","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","article-title":"Nuclear factor \u03baB signaling in atherogenesis","volume":"25","author":"De Winther","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0455","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00396","article-title":"Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation","volume":"5","author":"Gomolak","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0460","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jjcc.2014.10.012","article-title":"Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in Apo E-\/- mice","volume":"66","author":"Bhat","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0465","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6721531","article-title":"T cell-derived IL-17A induces vascular dysfunction via perivascular fibrosis formation and dysregulation of \u00b7NO\/cGMP signaling","volume":"2019","author":"Sch\u00fcler","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0470","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2017.03.017","article-title":"The interplay between Angiotensin II, TLR4 and hypertension","volume":"120","author":"Biancardi","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0475","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"Lin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0480","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00204-016-1830-8","article-title":"TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity","volume":"91","author":"Gonz\u00e1lez-Guerrero","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06484-6","article-title":"Toll-like receptor 4 deficiency reduces oxidative stress and macrophage mediated inflammation in hypertensive kidney","volume":"7","author":"Pushpakumar","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0490","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0495","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.4049\/jimmunol.1102527","article-title":"Induction of endothelial nitric oxide synthase expression by IL-17 in human vascular endothelial cells: implications for vascular remodeling in transplant vasculopathy","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0500","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cbin.10144","article-title":"In vitro effects of IL-17 on angiogenic properties of endothelial cells in relation to oxygen levels","volume":"37","author":"Krsti\u0107","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0505","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/HYPERTENSIONAHA.118.11212","article-title":"Interaction between hypertension and arterial stiffness an expert reappraisal","volume":"72","author":"Safar","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0510","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCRESAHA.114.302157","article-title":"Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase","volume":"114","author":"Wu","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0515","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","article-title":"Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration","volume":"59","author":"Liao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0530","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0535","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1159\/000430197","article-title":"Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment","volume":"36","author":"Yuan","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114647","article-title":"IL-17\/miR-192\/IL-17Rs regulatory feedback loop facilitates multiple myeloma progression","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0545","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/onc.2016.240","article-title":"Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0550","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/pros.23343","article-title":"Targeting Th17-IL-17 pathway in prevention of micro-invasive prostate cancer in a mouse model","volume":"77","author":"Zhang","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0555","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1168-1","article-title":"Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0560","article-title":"Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-\u03b21 mediated Smad2\/3 and ERK1\/2 activation","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0565","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/01.ATV.0000090130.85752.ED","article-title":"Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development","volume":"23","author":"Hao","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bcp.2016.08.012","article-title":"Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension","volume":"118","author":"Belo","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0575","doi-asserted-by":"crossref","first-page":"543","DOI":"10.33549\/physiolres.933779","article-title":"Akt\/eNOS and MAPK signaling pathways mediated the phenotypic switching of thoracic aorta vascular smooth muscle cells in aging\/hypertensive rats","volume":"67","author":"Zhang","year":"2018","journal-title":"Physiol Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0580","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2018.10.002","article-title":"Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension","volume":"116","author":"Blascke de Mello","year":"2019","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0585","first-page":"5160","article-title":"Age-associated alteration in T17 cell response is related to endothelial cell senescence and atherosclerotic cerebral infarction","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0590","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax3799","article-title":"Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans","volume":"12","author":"Chung","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0595","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1172\/JCI134091","article-title":"IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis","volume":"130","author":"Faust","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11906-010-0100-z","article-title":"Oxidative stress and hypertension: current concepts","volume":"12","author":"Briones","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11906-003-0014-0","article-title":"Molecular mechanisms of angiotensin II-induced vascular injury","volume":"5","author":"Ruiz-Ortega","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0610","first-page":"1137","article-title":"Molecular and cellular mechanisms regulating vascular function and structure \u2013 implications in the pathogenesis of hypertension","volume":"16","author":"Touyz","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0615","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2015.02.096","article-title":"Cross-talk between angiotensin-II and toll-like receptor 4 triggers a synergetic inflammatory response in rat mesangial cells under high glucose conditions","volume":"459","author":"Lv","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0620","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/01.CIR.103.9.1238","article-title":"Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus","volume":"103","author":"Rizzoni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0625","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/HJH.0b013e32805bf8ed","article-title":"Small artery structure is an independent predictor of cardiovascular events in essential hypertension","volume":"25","author":"Mathiassen","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0630","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","article-title":"Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II-induced hypertension","volume":"68","author":"Norlander","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0635","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","article-title":"Blood pressure control \u2014 special role of the kidneys and body fluids","volume":"252","author":"Guyton","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0640","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cmet.2015.11.013","article-title":"Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 Co-transporter in the nephron","volume":"23","author":"Zhang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0645","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MNH.0000000000000385","article-title":"Renal effects of cytokines in hypertension","volume":"27","author":"Wen","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0650","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","article-title":"Renal transporter activation during angiotensin-II hypertension is blunted in interferon-\u03b3-\/- and interleukin-17A-\/- mice","volume":"65","author":"Kamat","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0655","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/jcm9010272","article-title":"Could IL-17A be a novel therapeutic target in diabetic nephropathy?","volume":"9","author":"Lavoz","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.nefroe.2021.06.003_bib0660","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","article-title":"Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy","volume":"95","author":"Lavoz","year":"2019","journal-title":"Kidney Int"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:47:18Z","timestamp":1761853638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251421000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2013251421000572"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.06.003","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17A: Potential mediator and therapeutic target in hypertension","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2020.11.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}